Peptic Relief

Product NDC
24385-337
11-digit product format
243850337
Labeler code
24385
Product ID
24385-337_fcdfafb9-410d-458c-884b-6bdec248e31c
Type
HUMAN OTC DRUG
Nonproprietary name
Maximum Strength Pepto Bismol
Dosage form
SUSPENSION
Route
ORAL
Labeler
AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385
Application
part335
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2012-01-01
Marketing end
2019-12-31
Substance
BISMUTH SUBSALICYLATE
Active strength
525 mg/15mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct24385-337DDiscontinued by firm2026-10-05
excluded packagepackage24385-33724385-337-34DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage24385-337-34d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage24385-337-34f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage24385-337-342ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage24385-337-34a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage24385-337-34cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage24385-337-34cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage24385-337-34302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage24385-337-34ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage24385-337-340efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage24385-337-34ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage24385-337-34367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage24385-337-34557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24385-337-34ML - Milliliter24385-33768bdd9a9-9fb4-41eb-b552-997f0fa56cec12013-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BISMUTH SUBSALICYLATEACTIVE INGREDIENT62TEY51RR1PEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
BENZOIC ACIDINACTIVE INGREDIENT8SKN0B0MIMPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
D&C RED NO. 22INACTIVE INGREDIENT1678RKX8RTPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
MAGNESIUM ALUMINUM SILICATEINACTIVE INGREDIENT6M3P64V0NCPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
METHYLCELLULOSE (100 CPS)INACTIVE INGREDIENT4GFU244C4JPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
SALICYLIC ACIDINACTIVE INGREDIENTO414PZ4LPZPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1
SORBIC ACIDINACTIVE INGREDIENTX045WJ989BPEPTIC RELIEF MAXIMUM STRENGTH (MAXIMUM STRENGTH PEPTO BISMOL) SUSPENSION [GOOD NEIGHBOR PHARMACY]1